Jianping Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jianping Jin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Chonghua Li
Department of Biochemistry and Molecular Biology, Medical School, United States
2 shared publicationsJu-Mei Li
Department of Biochemistry and Molecular Biology, Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
2 shared publicationsDorothy E. Lewis
Department of Internal Medicine, Medical School, United States
1 shared publicationHongyu Wu
Department of Internal Medicine, Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA
1 shared publication- Michael R. Blackburn
Department of Biochemistry and Molecular Biology, McGovern Medical School at UTHealth, Houston, Texas, USA
1 shared publication - Natoya Peart
Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch at Galveston, Galveston, USA
1 shared publication
Latest Publications
- 15 March 2014
- Published by Elsevier in Cellular Signalling
- Vol. 26 (7) , 1369-1378
PMA induces SnoN proteolysis and CD61 expression through an autocrine mechanism
- 15 March 2014
- Published by Elsevier in Cellular Signalling
- Vol. 26 (7) , 1369-1378
PMA induces SnoN proteolysis and CD61 expression through an autocrine mechanism
- Open Access
- 1 February 2014
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 34 (3) , 335-347
The p97-UFD1L-NPL4 Protein Complex Mediates Cytokine-Induced IκBα Proteolysis
IκBα is an inhibitor of NF-κB, a family of transcription factors that transactivate genes related to inflammation. Upon inflammatory stimuli, IκBα is rapidly degraded via the ubiquitin-proteasome pathway. While it is very clear that the SCFβ-TRCP ubiquitin ligase ubiquitinates IκBα upon stimulation, little is known about the postubiquitinational events of IκBα proteolysis. Here, we report that p97, a valosin-containing protein (also called VCP), plays an essential role in the postubiquitinational regulation of IκBα turnover after tumor necrosis factor alpha (TNF-α) or interleukin-1β (IL-1β) treatment. The ATPase activity of p97 is essential for its role in IκBα proteolysis. Moreover, we found that UFD1L and NPL4, two cofactors of p97, assist p97 to control the postubiquitinational regulation of IκBα. The p97-UFD1L-NPL4 protein complex specifically associates with ubiquitinated IκBα via the interactions between p97 and the SCFβ-TRCP ubiquitin ligase and between the polyubiquitin binding domain of UFD1L and polyubiquitinated IκBα. Furthermore, we observed that the postubiquitinational regulation of IκBα by the p97-UFD1L-NPL4 complex is important for NF-κB activation under stimuli.
- 1 February 2014
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 34 (3) , 335-347
Open AccessThe p97-UFD1L-NPL4 Protein Complex Mediates Cytokine-Induced IκBα Proteolysis
IκBα is an inhibitor of NF-κB, a family of transcription factors that transactivate genes related to inflammation. Upon inflammatory stimuli, IκBα is rapidly degraded via the ubiquitin-proteasome pathway. While it is very clear that the SCFβ-TRCP ubiquitin ligase ubiquitinates IκBα upon stimulation, little is known about the postubiquitinational events of IκBα proteolysis. Here, we report that p97, a valosin-containing protein (also called VCP), plays an essential role in the postubiquitinational regulation of IκBα turnover after tumor necrosis factor alpha (TNF-α) or interleukin-1β (IL-1β) treatment. The ATPase activity of p97 is essential for its role in IκBα proteolysis. Moreover, we found that UFD1L and NPL4, two cofactors of p97, assist p97 to control the postubiquitinational regulation of IκBα. The p97-UFD1L-NPL4 protein complex specifically associates with ubiquitinated IκBα via the interactions between p97 and the SCFβ-TRCP ubiquitin ligase and between the polyubiquitin binding domain of UFD1L and polyubiquitinated IκBα. Furthermore, we observed that the postubiquitinational regulation of IκBα by the p97-UFD1L-NPL4 complex is important for NF-κB activation under stimuli.
- Open Access
- 1 January 2012
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 2, 21918
CRL Ubiquitin Ligases and DNA Damage Response
Cullin/RING ubiquitin ligases (CRL) comprise the largest subfamily of ubiquitin ligases. CRLs are involved in cell cycle regulation, DNA replication, DNA damage response (DDR), development, immune response, transcriptional regulation, circadian rhythm, viral infection, and protein quality control. One of the main functions of CRLs is to regulate the DDR, a fundamental signaling cascade that maintains genome integrity. In this review, we will discuss the regulation of CRL ubiquitin ligases and their roles in control of the DDR.
- 1 January 2012
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 2, 21918
Open AccessCRL Ubiquitin Ligases and DNA Damage Response
Cullin/RING ubiquitin ligases (CRL) comprise the largest subfamily of ubiquitin ligases. CRLs are involved in cell cycle regulation, DNA replication, DNA damage response (DDR), development, immune response, transcriptional regulation, circadian rhythm, viral infection, and protein quality control. One of the main functions of CRLs is to regulate the DDR, a fundamental signaling cascade that maintains genome integrity. In this review, we will discuss the regulation of CRL ubiquitin ligases and their roles in control of the DDR.
- Open Access
- 23 February 2010
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 1 (3) , 227-236
DNA replication licensing control and rereplication prevention
Eukaryotic DNA replication is tightly restricted to only once per cell cycle in order to maintain genome stability. Cells use multiple mechanisms to control the assembly of the prereplication complex (pre-RC), a process known as replication licensing. This review focuses on the regulation of replication licensing by posttranslational modifications of the licensing factors, including phosphorylation, ubiquitylation and acetylation. These modifications are critical in establishing the pre-RC complexes as well as preventing rereplication in each cell cycle. The relationship between rereplication and diseases, including cancer and virus infection, is discussed as well.
- 23 February 2010
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 1 (3) , 227-236
Open AccessDNA replication licensing control and rereplication prevention
Eukaryotic DNA replication is tightly restricted to only once per cell cycle in order to maintain genome stability. Cells use multiple mechanisms to control the assembly of the prereplication complex (pre-RC), a process known as replication licensing. This review focuses on the regulation of replication licensing by posttranslational modifications of the licensing factors, including phosphorylation, ubiquitylation and acetylation. These modifications are critical in establishing the pre-RC complexes as well as preventing rereplication in each cell cycle. The relationship between rereplication and diseases, including cancer and virus infection, is discussed as well.